Cardinal Health Inc. ($CAH) Stock Forecast: Down 1.4% Today

What is Cardinal Health Inc.?

Cardinal Health (CAH) is a healthcare services company operating in the pharmaceutical segment with a diversified product portfolio. Today, there has been a bearish sentiment towards CAH in the market.

Why is Cardinal Health Inc. going down?

CAH stock is down 1.4% on Dec 11, 2024 15:28

• The strength in CAH's pharmaceutical segment and diversified product portfolio was not enough to counterbalance the challenges of concentrated revenue generation and regulatory setbacks.
• Concerns about concentrated revenue generation and regulatory setbacks seemed to heavily influence investor sentiment, causing a decline in CAH's stock.
• Despite the positive aspects of the company's business segments, challenges mentioned earlier seemed to overshadow potential gains, resulting in today's bearish market movement for CAH.

CAH Price Chart

CAH Technical Analysis

CAH News

Strength Across Segments to Help CAH Stock Offset OptumRx Headwind?

CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, concentrated revenue generation and regulatory setbacks are a concern.

https://www.zacks.com/stock/news/2379340/strength-across-segments-to-help-cah-stock-offset-optumrx-headwind

Trending Today

Toncoin ($TON) Crypto Forecast: Up 10.7% Today

Hedera Hashgraph ($HBAR) Crypto Forecast: Up 5.9% Today

Bitcoin ($BTC) Crypto Forecast: Up 5.1% Today

XRP ($XRP) Crypto Forecast: Up 5.6% Today

Uniswap ($UNI) Crypto Forecast: Up 13.1% Today

Bittensor ($TAO) Crypto Forecast: Up 10.7% Today

Aave ($AAVE) Crypto Forecast: Up 13.7% Today

Pepe ($PEPE) Crypto Forecast: Up 10.9% Today

Shiba Inu ($SHIB) Crypto Forecast: Up 6.8% Today

Cardano ($ADA) Crypto Forecast: Up 7.7% Today

Cardinal Health Inc. Price History

01.10.2024 - CAH Stock was up 6.4%

• In the first quarter of 2025, Cardinal Health (CAH) posted strong results, surpassing adjusted EPS expectations and outperforming sales consensus. The success was mainly attributed to the robust performance of its drug distribution business.
• By revising its profit outlook for 2025 upwards, the company demonstrates confidence in its growth path and ability to seize opportunities within the healthcare industry.
• Following the impressive earnings announcement, the market reacted positively to Cardinal Health, resulting in a bullish trend in the stock price. Investors appreciated the company's solid financial performance and strategic efforts to navigate supply chain obstacles.

01.10.2024 - CAH Stock was up 6.3%

• Cardinal Health (CAH) experienced a strong bullish movement today following its Q1 earnings report:
• The company beat expectations with first-quarter fiscal 2025 results, driven by solid growth in Pharmaceutical and Specialty Solutions.
• Despite a decrease in sales due to the OptumRx contract expiry, the raised earnings per share (EPS) outlook for 2025 boosted investor confidence.
• The positive market reaction can be attributed to:
• Strong performance in the drug distribution business, leading to an increase in adjusted operating earnings.
• Continued growth prospects supported by new facilities, acquisitions, and overcoming supply chain challenges.
• The market's focus on CAH's robust financial performance overshadowed concerns about sector comparisons and potential competition from other medical stocks like Atossa Genetics (ATOS).
• Overall, Cardinal Health's resilience and strategic initiatives in the healthcare sector have positioned the company favorably, driving investor optimism and contributing to today's bullish market movement.

11.11.2024 - CAH Stock was down 1.4%

• The strength in CAH's pharmaceutical segment and diversified product portfolio was not enough to counterbalance the challenges of concentrated revenue generation and regulatory setbacks.
• Concerns about concentrated revenue generation and regulatory setbacks seemed to heavily influence investor sentiment, causing a decline in CAH's stock.
• Despite the positive aspects of the company's business segments, challenges mentioned earlier seemed to overshadow potential gains, resulting in today's bearish market movement for CAH.

30.05.2023 - CAH Stock was up 0.6%

• The bullish movement in CAH's stock today can be attributed to the following factors:
• 1. Institutional Investment: Allspring Global Investments Holdings LLC increased its stock position in Cardinal Health, indicating confidence in the company's future prospects. This positive sentiment from a major investor could have contributed to the bullish movement.
• 2. Distribution Agreement: Cardinal Health signed a distribution agreement with Tivic Health Systems, leading to a surge in Tivic Health Systems' stock. This partnership could have generated optimism about Cardinal Health's growth potential and positively impacted its stock price.
• 3. Market Performance: The overall healthcare services market has been performing well, with AmerisourceBergen receiving a composite rating upgrade. This suggests that the industry as a whole is outperforming other stocks, which could have influenced the bullish movement in CAH's stock.
• 4. Market Sentiment: While not directly related to Cardinal Health, other stocks in the healthcare sector, such as Black Diamond Therapeutics and Centogene N.V., experienced significant gains. This positive sentiment in the sector could have spilled over to Cardinal Health, contributing to its bullish movement.

03.10.2023 - CAH Stock was up 8.6%

• Cardinal Health reported Q1 FY24 adjusted EPS of $1.73, beating the consensus of $1.41.
• The company raised its profit outlook for FY2024 after reporting increased profit in the pharmaceutical and medical segments.
• Despite a slight decrease in Q1 profit compared to the same period last year, Cardinal Health beat Street estimates.
• The non-GAAP EPS of $1.73 beat expectations, although revenue fell slightly short.
• Overall, the bullish movement in CAH's stock can be attributed to the positive earnings report and the company's optimistic outlook for the future. The strong performance in the pharmaceutical and medical segments likely contributed to investor confidence in the stock.

27.05.2023 - CAH Stock was down 1.8%

• CAH had a strong bearish movement today.
• Sotera Health announced the appointment of Jon Lyons as their new CFO, which is not directly related to CAH, but could have caused some investors to shift their focus to Sotera Health instead.
• Despite hitting a 52-week high recently, CAH's bearish movement could be due to profit-taking by investors who are optimistic about the company's diversified product portfolio.

14.02.2024 - CAH Stock was down 5.1%

• The increase in Cardinal Health's short interest by 13.87% may have contributed to the bearish movement as higher short interest can indicate a lack of confidence in the stock's performance.
• The negative market sentiment towards Cardinal Health could be due to concerns about the company's ability to effectively manage its internal resource pool, as highlighted by another company's expansion of capabilities in healthcare system management.
• Investors might be cautious about Cardinal Health's financial performance, given the company's recent report of 4.27% of all regular shares being sold short, indicating a potential lack of faith in its future growth prospects.
• The overall market reaction to Cardinal Health's bearish movement could also be influenced by broader industry trends, such as the increasing focus on digital solutions in healthcare, as seen with collaborations in the pathology sector.

17.07.2023 - CAH Stock was down 5.2%

• The bearish movement in CAH stock today can be attributed to the following factors:
• 1. Disappointing Q2 Revenue: Despite beating Wall Street's expectations for earnings, Cardinal Health reported lower-than-expected revenue in its fiscal fourth quarter. This could have led to a decrease in investor confidence and a subsequent decline in the stock price.
• 2. Weight-Loss and Diabetes Drugs: While Cardinal Health attributed its strong Q4 growth to the increasing popularity of weight-loss and diabetes drugs in the GLP-1 class, it seems that this positive news was not enough to sustain the bullish momentum. Other factors may have overshadowed this positive development, leading to the bearish movement.
• 3. Overall Market Sentiment: The broader market sentiment and trends in the healthcare sector could have also influenced the bearish movement in CAH stock. Factors such as regulatory changes, healthcare policy discussions, and market volatility can impact investor sentiment and contribute to market movements.
• 4. External Factors: It's worth noting that the news articles provided do not directly mention any specific negative developments or events related to Cardinal Health. However, it's possible that external factors, such as market-wide concerns, global economic conditions, or industry-specific challenges, could have influenced the bearish movement in CAH stock.

15.06.2024 - CAH Stock was down 0.7%

• The bearish movement in CAH stock today could be attributed to regulatory setbacks. Regulatory challenges can impact the company's operations and profitability, leading to negative investor sentiment.
• Despite being highlighted as an undervalued dividend stock, the market might be reacting to specific concerns, overshadowing the potential long-term benefits of investing in dividend stocks.
• The overall market improvement may have had a limited impact on CAH stock, indicating that company-specific factors are currently driving the stock price movement more significantly than broader market trends.
• Investors should closely monitor any updates regarding regulatory issues and how Cardinal Health addresses them to gauge the future trajectory of the stock.

14.07.2024 - CAH Stock was up 5.1%

• Cardinal Health Inc.'s stock experienced a strong bullish movement today.
• The surprising 11% stock rally can be attributed to the company exceeding fourth-quarter earnings and revenue estimates, driven by strong sales of pharmaceuticals.
• The positive earnings report, where Cardinal Health beat EPS and revenue expectations, along with raising its EPS guidance for fiscal 2024, likely fueled investor optimism and contributed to the bullish market movement.
• The market's positive reaction indicates investor confidence in Cardinal Health's financial performance and outlook, positioning the company favorably in the healthcare services sector.

14.07.2024 - CAH Stock was up 5.9%

• Cardinal Health (CAH) surpassed expectations on Q4 earnings and raised its EPS guidance for fiscal 2024, showcasing solid profit growth in Pharmaceutical and Specialty Solutions.
• The robust Q4 results and raised outlook contributed to the positive market sentiment towards CAH stock.
• The strong performance of Cardinal Health overshadowed concerns in the healthcare sector, as indicated by the warning of potential crashes in other health care stocks.
• Overall, the optimistic outlook and financial performance of Cardinal Health drove the bullish movement in its stock, demonstrating investor confidence in the company's future prospects.

14.07.2024 - CAH Stock was up 5.0%

• Fourth-quarter 2024 adjusted EPS for Cardinal Health was reported at $1.84, showing a 29% increase year over year and surpassing consensus expectations. This positive earnings report likely contributed to the bullish movement in the stock.
• The company raised its fiscal 2025 adjusted earnings forecast above market expectations, indicating strong performance and future growth prospects.
• The market reacted positively to Cardinal Health's profit in the fourth quarter and its plans for a buyback, resulting in a more than 7% increase in the stock price during pre-market trading.
• The overall positive sentiment towards Cardinal Health, coupled with its strong financial performance and strategic initiatives, drove the stock to a bullish trajectory today.